Notably, RB1 inactivation appeared to be a key factor contributing to CIN in SCLC, supported by the observation that patients harboring RB1 inactivation exhibited higher wGII scores than those with wild-type RB1 (P = 0.03, Fig. 6B). This evidence concerns the gene RB1 and small cell lung carcinoma.